Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00147485
Status:
TERMINATED
Last Update Posted:
2008-08-18
First Post:
2005-09-02
Brief Title:
A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer
Sponsor:
Organization:
Pfizer